A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically III patients: A qualitative and quantitative systematic review

Anesthesia and Analgesia

Volumn 92, Issue 4, 2001, Pages 975-983

  Walder, Bernhard ^a   Elia, Nadia ^a   Henzi, Iris ^a   Romand, Jacques R ^a   Tramèr, Martin R ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MIDAZOLAM; PROPOFOL;

ANESTHETIC RECOVERY; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG EFFICACY; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INTENSIVE CARE; META ANALYSIS; PRIORITY JOURNAL; SEDATION; VALIDATION PROCESS;

EID: 0035076456     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200104000-00033     Document Type: Article

References (61)

1. Sedation of critically ill patients during mechanical ventilation: A comparison of propofol and midazolam
2. Sedation for the critically ill neurologic patient
3. Evaluation and treatment of agitation in the intensive care unit
4. Status epilepticus
5. Actions of the general anesthetic propofol on recombinant human GABAA receptors: Influence of receptor subunits
6. Midazolam inhibits long-term potentiation through modulation of GABAA receptors
7. Induction and recovery characteristics of propofol, thiopental and etomidate
8. Haemodynamic and oxygen transport effects of propofol infusion in critically ill adults
9. Propofol and bradycardia: Causation, frequency and severity
10. Postoperative infections traced to contamination of an intravenous anesthetic, propofol
11. Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and costs
12. A review of the safety and tolerance of propofol ('Diprivan')
13. Seizures and opisthotonus after propofol anesthesia: A possible connection
14. Prolonged sedation due to accumulation of conjugated metabolites of midazolam
15. The effect of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam
16. Comparison of propofol and midazolam for sedation in critically ill patients
17. Midazolam versus propofol for long-term sedation in the ICU: A randomized prospective comparison
18. Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients: A cost-benefit analysis
19. Improving the quality of reports of meta-analysis of randomised controlled trials: The QUOROM statement
20. Propofol: An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation
21. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens
22. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
23. Statistics with confidence: Confidence intervals and statistical guideline
24. Beta blockade during and after myocardial infarction: An overview of the randomized trials
25. Meta-analysis in clinical trials
26. The number needed to treat: A clinically useful measure of treatment effect
27. Using numerical results from systematic reviews in clinical practice
28. Long-term sedation in the intensive care unit: A comparison of propofol with midazolam
29. Long-term sedation (24h) in the intensive care unit: A comparison of propofol and midazolam
30. Propofol versus midazolam: Long-term sedation in the intensive care unit
31. Urine and plasma catecholamine and cortisol concentrations after myocardial revascularization: Modulation by continuous sedation
32. Cardiovascular responses during sedation after coronary revascularization: Incidence of myocardial ischemia and hemodynamic episodes with propofol versus midazolam - Institutions of the McSPI Research Group
33. Infusion of propofol, sufentanil, or midazolam for sedation after aortic surgery: Comparison of oxygen consumption and hemodynamic stability
34. A cost analysis of alfentanil + propofol vs morphine + midazolam for the sedation of critically ill patients
35. Propofol for long-term sedation in the intensive care unit: A comparison with papaveretum and midazolam
36. Propofol vs. midazolam in combination with sufentanil for continuous sedation in the neurosurgical unit
37. Overnight sedation with midazolam or propofol in the ICU: Effects on sleep quality, anxiety and depression
38. A pilot study to compare the use of propofol and midazolam for long-term sedation
39. Propofol or midazolam for short-term alterations in sedation
40. Long-term sedative infusion in the intensive care unit: Propofol versus midazolam
41. Comparative study of propofol versus midazolam in the sedation of critically ill patients: Results of a prospective, randomized, multicenter trial
42. Sedation after cardiac bypass surgery: Comparison of propofol and midazolam in the presence of a computerized closed loop arterial pressure controller
43. Propofol compared with midazolam for sedation following prolonged neurosurgery
44. Cost of ICU sedation: Comparison of empirical and controlled sedation methods
45. A study to compare the use of propofol and midazolam for the sedation of patients with acute respiratory failure
46. A comparison of propofol and midazolam for long-term sedation of ventilated patients: A cross-over study
47. Propofol infusion for sedation in the intensive care unit: Preliminary report
48. Propofol versus midazolam for intensive care unit sedation after coronary artery bypass grafting
49. Propofol sedation after open heart surgery. A clinical and pharmacokinetic study
50. Infusion of propofol versus midazolam for sedation in the intensive care unit following coronary artery surgery
51. Comparison of propofol and midazolam for sedation in intensive care unit patients
52. Propofol versus midazolam: Safety and efficacy for sedating the severe trauma patient
53. Propofol or midazolam for sedation and early extubation following cardiac surgery
54. The use of midazolam versus propofol for short-term sedation following coronary artery bypass grafting
55. A comparison of propofol/fentanyl and midazolam/fentanyl for ICU sedation after abdominal surgery
56. Controlled sedation with alphaxalone-alphadolone
57. Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients
58. Pharmacokinetics of midazolam in patients recovering from cardiac surgery
59. Size is everything-large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects
60. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs